Intravenous in-line filters for preventing morbidity and mortality in neonates

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Foster, Jann P ^a,b,c   Richards, Robyn ^d   Showell, Marian G ^e   Jones, Lisa J ^b  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INFUSION FLUID; PLACEBO;

CATHETERIZATION; HUMAN; INTRAVENOUS IN LINE FILTER; LENGTH OF STAY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPTICEMIA; SYSTEMATIC REVIEW; THROMBUS; ADVERSE EFFECTS; DEVICES; DRUG CONTAMINATION; FILTRATION; INFANT; INFANT MORTALITY; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; PREMATURITY;

CATHETERIZATION, PERIPHERAL; DRUG CONTAMINATION; FILTRATION; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84991258740     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005248.pub3     Document Type: Review

References (40)

1. Bennion D, Martin K. In-line filtration. Paediatric Nursing 1991;June:20-21.
2. Thomas PH. In-line terminal filtration of intravenous fluids and its effect on cannula patency in neonates. Proceedings - Guild of Hospital Pharmacy 2004;26:3-10.
3. van den Hoogen A, Krediet TG, Uiterwaal C, Bolenius J, Gerards LJ, Fleer A. In-line filters in central venous catheters in a neonatal intensive care unit. Journal of Perinatal Medicine 2006;34(1):71-74. [PUBMED: 16489888]
4. van Lingen RA, Baerts W, Marquering AC, Ruijs GJ. The use of in-line intravenous filters in sick newborn infants. Acta Paediatrica 2004;93(5):658-62. [PUBMED: 15174791]
5. Jack T, Boehne M, Brent BE, Hoy L, Köditz H, Wessel A, et al. In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Medicine 2012;38(6):1008-16. [PUBMED: 22527062]
6. Allcutt DA, Lort D, McCollum CN. Final inline filtration for intravenous infusions: a prospective hospital study. British Journal of Surgery 1983;70(2):111-13. [PUBMED: 6824894]
7. Backhouse CM, Ball PR, Booth S, Kelshaw MA, Potter SR, McCollum CN. Particulate contaminants of intravenous medications and infusions. Journal of Pharmacy and Pharmacology 1987;39(4):241-5. [PUBMED: 2884285]
8. Ball PA. Intravenous in-line filters: filtering the evidence. Current Opinion in Cinical Nutrition and Metabolic Care 2003;6(3):319-25. [PUBMED: 12690266]
9. Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: a ten year experience. Journal of Pediatrics 1990;117(1 Pt 2):S6-13. [PUBMED: 2362230]
10. Barnett MI, Cosslett AG. Endotoxin retention capabilities of positively charged nylon and positively charged polysulphone membrane intravenous filters. Pharmacy and Pharmacology Communications 1996;2(7):319-20.
11. Bethune K, Allwood M, Grainger C, Wormleighton C, British Pharmaceutical Nutrition Group Working Party. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition 2001;17(5):403-8. [PUBMED: 11377134]
12. Casale TB, Ballas ZK, Kaliner MA, Keahey TM. The effects of intravenous endotoxin on various host-effector molecules. Journal of Allergy and Clinical Immunology 1990;85(1 Pt 1):45-51. [PUBMED: 2137152]
13. Chee S, Tan W. Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. Journal of Infusion Nursing 2002;25(2):95-104. [PUBMED: 11984223]
14. Evans C, Dixon A. Intravenous therapy: practice issues. Infant 2006;2(4):133-9.
15. Friedland G. Infusion-related phlebitis-is the in-line filter the solution?. New England Journal of Medicine 1985;312(2):113-5. [PUBMED: 3964914]
16. Garvan JM, Gunner BW. The harmful effects of particles in intravenous fluids. Medical Journal of Australia 1964;12:1-6. [PUBMED: 14175312]
17. Geiss HK, Batzer A, Sonntag HG. Investigations on the retention of microorganisms by inline-filters for intravenous infusions in ICU patients. Hygiene Und Medizin 1992;17:421-6.
18. Gilles FH, Averill DR Jr, Kerr CS. Neonatal endotoxin encephalopathy. Annals of Neurology 1977;2(1):49-56. [PUBMED: 409336]
19. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991;338(8769):732-6. [PUBMED: 1679876]
20. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
21. Hill A, Volpe JJ. Textbook of Neonatology. 2nd Edition. London: Churchill Livingstone, 1992.
22. Kirkpatrick CJ. Particulate matter in intravenous fluids: the importance for medicine. Krankenhauspharmazie 1988;9:487-90.
23. Koekenberg H. A case for I.V. filtration. Infusion 1983;7:76-82.
24. Kunac DL, Ball PA, Broadbent RS. In-line intravenous filtration in neonates-help not hindrance. Australian Journal of Hospital Pharmacy 1999;29:321-27.
25. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Annals of Internal Medicine 1991;114(10):845-54. [PUBMED: 2014945]
26. Marshall L, Lloyd G. Intravenous fluid infiltration. Care of the Critically Ill 1987;3:10-17.
27. Newell F, Ranson K, Robertson J. Use of in-line filters in pediatric intravenous therapy. Journal of Intravenous Nursing 1998;21(3):166-70. [PUBMED: 9652276]
28. Ng PC, Herrington RA, Beane CA, Ghoneim AT, Dear PR. An outbreak of acinetobacter septicaemia in a neonatal intensive care unit. Journal of Hospital Infection 1989;14(4):363-8. [PUBMED: 2575636]
29. O'Dwyer ST, Michie HR, Zeigler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Archives of Surgery 1988;123(12):1459-64. [PUBMED: 3142442]
30. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention 2011; Vol. http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html:1-59.
31. Parsons PE, Worthen GS, Moore EE, Tate RM, Henson PM. The association of circulating endotoxin with the development of adult respiratory distress syndrome. American Review of Respiratory Diseases 1989;140(2):294-301. [PUBMED: 2764364]
32. Pearson ML. Guideline for prevention of intravascular device-related infections: Part 1. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. American Journal of Infection Control 1996;24(4):262-77.
33. Quercia RA, Hills SW, Klimek JJ, McLaughlin JC, Nightingale CH, Drezner AD, et al. Bacteriologic contamination of intravenous infusion delivery systems in an intensive care unit. American Journal of Medicine 1986;80(3):364-8. [PUBMED: 3513558]
34. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
35. Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. The Annals of Pharmacotherapy 1994;28(1):11-6. [PUBMED: 8123947]
36. Shaw NJ, Lyall EG. Hazards of glass ampoules. British Medical Journal (Clinical Research Ed) 1985;291(6506):1390. [PUBMED: 3933681]
37. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. New England Journal of Medicine 1989;320(18):1165-72. [PUBMED: 2496309]
38. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. New England Journal of Medicine 1989;321(5):280-7. [PUBMED: 2664516]
39. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatric Research 2001;50(5):553-62. [PUBMED: 11641446]
40. Foster JP, Richards R, Showell MG. Intravenous in-line filters for preventing morbidity and mortality in neonates. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005248.pub2]